(RTTNews) - Myers Industries Inc. (MYE) released earnings for its fourth quarter that Increases, from last year The company's bottom line totaled $11.33 million, or $0.30 per share. This compares with $4.30 million, or $0.11 per share, last year. Excluding items, Myers Industries Inc. reported adjusted earnings of $11.62 million or $0.31 per share for the period. The company's revenue for the peri...
(RTTNews) - Myers Industries Inc. (MYE) released earnings for its fourth quarter that Increases, from last year The company's bottom line totaled $11.33 million, or $0.30 per share. This compares with $4.30 million, or $0.11 per share, last year. Excluding items, Myers Industries Inc. reported adjusted earnings of $11.62 million or $0.31 per share for the period. The company's revenue for the period rose 0.0% to $203.97 million from $203.88 million last year. Myers Industries Inc. earnings at a glance (GAAP) : -Earnings: $11.33 Mln. vs. $4.30 Mln. last year. -EPS: $0.30 vs. $0.11 last year. -Revenue: $203.97 Mln vs. $203.88 Mln last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Stratasys press release ( SSYS ): Q4 Non-GAAP EPS of $0.07 beats by $0.01 . Revenue of $140M (-6.9% Y/Y) beats by $0.68M . Fourth quarter positive operating cash flow of $4.8 million. Strong balance sheet with $244.5 million cash, equivalents and short-term deposits and no debt at year-end 2025. Fourth quarter Adjusted EBITDA of $9.2 million, 6.6% of revenue. Outlook: Full year revenue growing to ...
Stratasys press release ( SSYS ): Q4 Non-GAAP EPS of $0.07 beats by $0.01 . Revenue of $140M (-6.9% Y/Y) beats by $0.68M . Fourth quarter positive operating cash flow of $4.8 million. Strong balance sheet with $244.5 million cash, equivalents and short-term deposits and no debt at year-end 2025. Fourth quarter Adjusted EBITDA of $9.2 million, 6.6% of revenue. Outlook: Full year revenue growing to $565 million to $575 million vs. $565.62M consensus , improving sequentially through the year. Based on current logistics and materials costs, full year non-GAAP gross margins of 46.7%-47.1%, including approximately $7 million of adverse impact from tariffs and foreign exchange rates relative to 2025. Full year non-GAAP operating expenses ranging from $260 million to $262 million, including approximately $10 million of adverse impact from changes in foreign exchange rates. Full year non-GAAP operating margins in a range of 0.7% to 1.5%. GAAP net loss of $83 million to $67 million, or ($0.95) to ($0.76) per diluted share. Non-GAAP net income of $8 million to $12.5 million, or $0.09 to $0.14 per diluted share vs. $0.24 consensus. Adjusted EBITDA of $25 million to $30 million, reflecting Adjusted EBITDA margin of 4.5% to 5.0%. Capital expenditures of $20 million to $25 million. Expects to generate positive operating cash flow subject to uncertainty around foreign exchange rates and tariffs. More on Stratasys Stratasys: Mass Adoption Concerns Remain Seeking Alpha’s Quant Rating on Stratasys Historical earnings data for Stratasys Financial information for Stratasys
Bioventus press release ( BVS ): Q4 Non-GAAP EPS of $0.24 beats by $0.02 . Revenue of $157.9M (+2.8% Y/Y) beats by $2.95M . Bioventus introduced its financial guidance for full-year 2026. The Company expects: Net sales of $600 million to $610 million vs $604.18M consensus. This reflects growth of approximately 6% to 7%. Adjusted EPS* of $0.73 to $0.77 vs $0.77 consensus. This reflects an increase ...
Bioventus press release ( BVS ): Q4 Non-GAAP EPS of $0.24 beats by $0.02 . Revenue of $157.9M (+2.8% Y/Y) beats by $2.95M . Bioventus introduced its financial guidance for full-year 2026. The Company expects: Net sales of $600 million to $610 million vs $604.18M consensus. This reflects growth of approximately 6% to 7%. Adjusted EPS* of $0.73 to $0.77 vs $0.77 consensus. This reflects an increase of approximately 7% to 13%. Cash from Operations of $82 million to $87 million. More on Bioventus Bioventus Inc. (BVS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Bioventus Inc. (BVS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Seeking Alpha’s Quant Rating on Bioventus Historical earnings data for Bioventus Financial information for Bioventus
This article first appeared on GuruFocus. Advanced Micro Devices (NASDAQ:AMD) rose nearly 6% on Wednesday. This sharp rally was driven by strong demand for artificial intelligence (AI) processors and growing catalysts from major collaborations with Meta Platforms (NASDAQ:META). The agreement with Meta covers a 6-gigawatt deployment using AMD's Instinct GPUs to support the social media company's AI...
This article first appeared on GuruFocus. Advanced Micro Devices (NASDAQ:AMD) rose nearly 6% on Wednesday. This sharp rally was driven by strong demand for artificial intelligence (AI) processors and growing catalysts from major collaborations with Meta Platforms (NASDAQ:META). The agreement with Meta covers a 6-gigawatt deployment using AMD's Instinct GPUs to support the social media company's AI systems. The move highlights AMD's growing footprint in AI infrastructure, as businesses increasingly invest in AI technologies. In addition, AMD introduced its Ryzen AI 400 series processors, aimed at next-generation AI-enabled laptops and computers. CEO Lisa Su said demand for the company's chips has exceeded expectations, reflecting rapid adoption of AI across commercial sectors. AMD also unveiled a $150 million partnership with Nutanix (NTNX) to develop a new AI platform and announced a research lab at the University of Toronto to advance chip development. The stock ended the day at $202, recovering from earlier weekly declines linked to global market pressures, including higher oil prices and geopolitical tensions.
(RTTNews) - Ciena Corp. (CIEN) reported a profit for its first quarter that Increases, from the same period last year The company's bottom line came in at $150.28 million, or $1.03 per share. This compares with $44.57 million, or $0.31 per share, last year. Excluding items, Ciena Corp. reported adjusted earnings of $197.34 million or $1.35 per share for the period. The company's revenue for the pe...
(RTTNews) - Ciena Corp. (CIEN) reported a profit for its first quarter that Increases, from the same period last year The company's bottom line came in at $150.28 million, or $1.03 per share. This compares with $44.57 million, or $0.31 per share, last year. Excluding items, Ciena Corp. reported adjusted earnings of $197.34 million or $1.35 per share for the period. The company's revenue for the period rose 33.1% to $1.427 billion from $1.072 billion last year. Ciena Corp. earnings at a glance (GAAP) : -Earnings: $150.28 Mln. vs. $44.57 Mln. last year. -EPS: $1.03 vs. $0.31 last year. -Revenue: $1.427 Bln vs. $1.072 Bln last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Advanced Micro Devices AMD rose nearly 6% on Wednesday. This sharp rally was driven by strong demand for artificial intelligence (AI) processors and growing catalysts from major collaborations with Meta Platforms META. The agreement with Meta covers a 6-gigawatt deployment using AMD's Instinct GPUs to support the social media company's AI systems. The move highlights AMD's growing footprint in AI ...
Advanced Micro Devices AMD rose nearly 6% on Wednesday. This sharp rally was driven by strong demand for artificial intelligence (AI) processors and growing catalysts from major collaborations with Meta Platforms META. The agreement with Meta covers a 6-gigawatt deployment using AMD's Instinct GPUs to support the social media company's AI systems. The move highlights AMD's growing footprint in AI infrastructure, as businesses increasingly invest in AI technologies. In addition, AMD introduced its Ryzen AI 400 series processors, aimed at next-generation AI-enabled laptops and computers. CEO Lisa Su said demand for the company's chips has exceeded expectations, reflecting rapid adoption of AI across commercial sectors. AMD also unveiled a $150 million partnership with Nutanix (NTNX) to develop a new AI platform and announced a research lab at the University of Toronto to advance chip development. The stock ended the day at $202, recovering from earlier weekly declines linked to global market pressures, including higher oil prices and geopolitical tensions.
The Japanese carmaker Nissan has said it could be forced to close its plant in Sunderland if the UK is not fully included in new “Made in Europe” manufacturing rules proposed by the EU. The UK car industry trade representative group also said it was “gravely concerned” about the proposals it said could damage the £70bn annual cross-channel trade. Under the EU plans, public subsidies to speed up th...
The Japanese carmaker Nissan has said it could be forced to close its plant in Sunderland if the UK is not fully included in new “Made in Europe” manufacturing rules proposed by the EU. The UK car industry trade representative group also said it was “gravely concerned” about the proposals it said could damage the £70bn annual cross-channel trade. Under the EU plans, public subsidies to speed up the development of electric vehicles would only be available to EVs made in European plants. Unveiled by the competition commissioner, Stéphane Séjourné, on Wednesday, the proposed Industrial Accelerator Act (IAA) is designed to protect the EU from cheap competition from China. According to reports on Thursday, Nissan has privately warned the UK government it could be forced to close if the proposals became law. One industry executive told the Financial Times that Nissan could face “an existential threat” if it was “frozen out of access to EU incentives”. The company’s Sunderland site is Britain’s biggest car factory, with 6,000 employees and the theoretical ability to make 600,000 cars a year. However, it is operating significantly below capacity because of lower demand. View image in fullscreen Workers inspect a car as it comes off the production line at Nissan’s factory at Sunderland. Photograph: Christopher Thomond/The Guardian The UK car industry said the attempt to prioritise EU-made products to accelerator green tech including electric vehicles must include trusted partners in the UK. Mike Hawes, the chief executive of the Society of Motor Manufacturers and Traders, the main UK auto sector lobby group, said: “The UK automotive sector is gravely concerned by [the] “Made in Europe” proposals set out in the European Commission’s Industrial Accelerator Act. As drafted, it would discriminate against UK-made vehicles and components, damaging a trading relationship worth almost £70bn annually.” He said he feared the IAA would “effectively put UK manufacturers at a systemic co...
Rentokil Initial NYSE: RTO executives told investors the company saw “encouraging progress” in 2025, led by improving performance in North America during the second half of the year and continued margin expansion at the group level. Management emphasized that revised commercial initiatives, a broader multi-brand strategy, and cost-efficiency actions helped strengthen key operating metrics, while f...
Rentokil Initial NYSE: RTO executives told investors the company saw “encouraging progress” in 2025, led by improving performance in North America during the second half of the year and continued margin expansion at the group level. Management emphasized that revised commercial initiatives, a broader multi-brand strategy, and cost-efficiency actions helped strengthen key operating metrics, while free cash flow came in well ahead of guidance. Get Rentokil Initial alerts: Sign Up 2025 financial performance and cash generation Group revenue increased 3.8% to $6.9 billion in 2025, with organic revenue growth of 2.6%. Adjusted operating profit rose 5.4% to just over $1 billion, producing a group adjusted operating margin of 15.5%, up 30 basis points year-over-year. Adjusted basic EPS increased 2.4% to $0.2591. The company reported an adjusted interest charge of $204 million, up $29 million, which CFO Paul Edgecliff said reflected the cost of additional bond debt issued during the year. The adjusted effective tax rate was 25.3%. Edgecliff highlighted cash performance as a key theme, with free cash flow from continuing operations up 24.5% to $615 million and free cash flow conversion of 98%, ahead of prior guidance of 80%. He attributed the result to disciplined working capital management and one-off benefits including $20 million of real estate sales. Working capital outflow improved by $67 million to an outflow of $59 million, helped by debtor management and supplier harmonization. Net debt ended the year at $3.65 billion versus $4.0 billion at the start of the period, although Edgecliff noted an adverse $181 million FX translation movement. Leverage improved to 2.6x from 2.9x, bringing the company closer to its target range of 2.0x to 2.5x. The board recommended a full-year dividend of $0.1239 per share, up 3%. North America: improving organic growth, operational focus, and efficiency actions North America revenue grew 3.2% to $4.3 billion, with organic growth of 2.3%. ...
Regenxbio press release ( RGNX ): Q4 GAAP EPS of -$1.30 misses by $0.36 . Revenue of $30.34M (+43.0% Y/Y) misses by $15.14M . REGENXBIO expects its balance in cash, cash equivalents and marketable securities of $240.9 million as of December 31, 2025 to fund its operations into early 2027. More on Regenxbio Regenxbio: Cautiously Bullish After FDA Setbacks REGENXBIO: Key FDA Decision On Hunter Syndr...
Regenxbio press release ( RGNX ): Q4 GAAP EPS of -$1.30 misses by $0.36 . Revenue of $30.34M (+43.0% Y/Y) misses by $15.14M . REGENXBIO expects its balance in cash, cash equivalents and marketable securities of $240.9 million as of December 31, 2025 to fund its operations into early 2027. More on Regenxbio Regenxbio: Cautiously Bullish After FDA Setbacks REGENXBIO: Key FDA Decision On Hunter Syndrome Just Weeks Away REGENXBIO Inc. (RGNX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Regenxbio Q4 2025 Earnings Preview Regenxbio dealt win by appeals court in patent spat with Sarepta
Dover Corporation’s DOV subsidiary Hillphoenix has expanded its CO2 refrigeration portfolio with the launch of the Next Generation Flex Mini, a compact, high-efficiency transcritical CO2 system designed for food retail and industrial markets. The Flex Mini platform enhances sustainability and operational performance by utilizing natural refrigerant CO2, which offers significantly lower global warm...
Dover Corporation’s DOV subsidiary Hillphoenix has expanded its CO2 refrigeration portfolio with the launch of the Next Generation Flex Mini, a compact, high-efficiency transcritical CO2 system designed for food retail and industrial markets. The Flex Mini platform enhances sustainability and operational performance by utilizing natural refrigerant CO2, which offers significantly lower global warming potential compared to traditional HFC systems. Key benefits include improved energy efficiency through advanced low-pressure ejector technology, reduced maintenance requirements with a filter-less oil separator and integrated bypass valves for streamlined serviceability, and flexible configuration options such as dual-brand compressor compatibility. The platform accommodates various voltage requirements and is available with weather-resistant, sound-attenuated and cold-weather configurations, allowing it to perform reliably across a wide range of operating conditions. The introduction reinforces Dover’s leadership in sustainable refrigeration technology, enabling food retailers and industrial users to enhance energy efficiency, reduce lifecycle expenses and align with tightening environmental standards. Shares of DOV are up 19.2% over the past year compared with the industry’s 23.7% rise. Image Source: Zacks Investment Research DOV’s Zacks Rank & Key Picks DOV carries a Zacks Rank of #3 (Hold). Better-ranked stocks in the Industrial Products space include Flowserve Corporation FLS, Helios Technologies, Inc. HLIO, and Crane Company CR. FLS and HLIO sport a Zacks Rank of #1 (Strong Buy), while CR carries a Zacks Rank of #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. The Zacks Consensus Estimate for FLS’s current-year earnings is pegged at $4.11 per share, indicating a 13% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average earnings surprise being 17.32%. The Zacks Co...
This article first appeared on GuruFocus. Palantir Technologies (PLTR, Financials) is facing pressure to remove artificial intelligence tools developed by Anthropic from a key U.S. military software platform after the government ordered contractors to halt work with the AI startup. Palantir's Maven Smart Systems platform, which helps military agencies analyze intelligence data and support weapons ...
This article first appeared on GuruFocus. Palantir Technologies (PLTR, Financials) is facing pressure to remove artificial intelligence tools developed by Anthropic from a key U.S. military software platform after the government ordered contractors to halt work with the AI startup. Palantir's Maven Smart Systems platform, which helps military agencies analyze intelligence data and support weapons targeting, reportedly relies on prompts and workflows built using Anthropic's Claude AI model, according to people familiar with the matter. The challenge follows an order from U.S. President Donald Trump directing government contractors to stop working with Anthropic after the company clashed with the Pentagon over safety guardrails tied to autonomous weapons and surveillance technology. As a result, Palantir may need to replace Claude with another AI model and rebuild parts of its Maven platform. One source said the process could take months, although U.S. Defense Secretary Pete Hegseth has called for the change to take effect immediately. Palantir holds contracts related to Maven with the U.S. Department of Defense and other national security agencies that could be worth more than $1 billion. Defense contractors such as Lockheed Martin may also need to remove Anthropic's AI tools from their systems, potentially creating broader disruptions as government agencies unwind ties with the AI company.
Altimmune press release ( ALT ): Q4 GAAP EPS of -$0.27 misses by $0.03 . Revenue of $0.03M beats by $0.03M (vs. $5K in Q4). Cash, cash equivalents and short-term investments of $274 million as of December 31, 2025; Balance sheet further strengthened through $75 million registered direct offering in January 2026. More on Altimmune Altimmune Outlook: Where Pemvidutide Phase 3 Is Heading In 2026 Alti...
Altimmune press release ( ALT ): Q4 GAAP EPS of -$0.27 misses by $0.03 . Revenue of $0.03M beats by $0.03M (vs. $5K in Q4). Cash, cash equivalents and short-term investments of $274 million as of December 31, 2025; Balance sheet further strengthened through $75 million registered direct offering in January 2026. More on Altimmune Altimmune Outlook: Where Pemvidutide Phase 3 Is Heading In 2026 Altimmune: Why Breakthrough Status Isn't A 'Buy' Signal Just Yet Altimmune: Pemvidutide's 48-Week Data Confirms The Market's Smokescreen Altimmune prices $75M direct offering Altimmune gains on FDA breakthrough designation for MASH therapy
(RTTNews) - Burlington Stores, Inc. (BURL) announced earnings for its fourth quarter that Increases, from last year The company's earnings totaled $310.39 million, or $4.84 per share. This compares with $260.77 million, or $4.02 per share, last year. Excluding items, Burlington Stores, Inc. reported adjusted earnings of $313.89 million or $4.89 per share for the period. The company's revenue for t...
(RTTNews) - Burlington Stores, Inc. (BURL) announced earnings for its fourth quarter that Increases, from last year The company's earnings totaled $310.39 million, or $4.84 per share. This compares with $260.77 million, or $4.02 per share, last year. Excluding items, Burlington Stores, Inc. reported adjusted earnings of $313.89 million or $4.89 per share for the period. The company's revenue for the period rose 11.3% to $3.647 billion from $3.277 billion last year. Burlington Stores, Inc. earnings at a glance (GAAP) : -Earnings: $310.39 Mln. vs. $260.77 Mln. last year. -EPS: $4.84 vs. $4.02 last year. -Revenue: $3.647 Bln vs. $3.277 Bln last year. -Guidance: Next quarter EPS guidance: $ 1.60 To $ 1.75 Next quarter revenue guidance: 9 % To 11 % The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
"At the same time, we want to keep modernising the BBC and find new ways to open up our thinking, plans and decision making to our audience, so they are more involved and play a greater role in the BBC of the future."
"At the same time, we want to keep modernising the BBC and find new ways to open up our thinking, plans and decision making to our audience, so they are more involved and play a greater role in the BBC of the future."
More than 18,600 canines from across the globe will strut their paws around the halls of Birmingham's NEC over the next three days, with owners hoping to win the ultimate title of Best in Show at Crufts.
More than 18,600 canines from across the globe will strut their paws around the halls of Birmingham's NEC over the next three days, with owners hoping to win the ultimate title of Best in Show at Crufts.